| Serial Number | 79415256 |
| Word Mark | PIMJETMI |
| Filing Date | Thursday, November 28, 2024 |
| Status | 640 - NON-FINAL ACTION COUNTED - NOT MAILED |
| Status Date | Friday, May 23, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceuticals, namely preparations for the treatment of cardiovascular, diabetic, dermatological, endocrinological, gastroenterological, genetic, hormonal, infectious, immunological, inflammatory, metabolic, musculoskeletal, neurological, oncological, ophthalmic, psychiatric, pulmonary, reproductive health, respiratory, rheumatological, thyroid diseases and disorders, and viral infections |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 6, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | MERCK Kommanditgesellschaft auf Aktien |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Event Date | Event Description |
| Thursday, February 6, 2025 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, January 23, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, February 6, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 20, 2025 | ASSIGNED TO EXAMINER |
| Thursday, February 6, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, May 23, 2025 | NON-FINAL ACTION WRITTEN |
| Saturday, May 24, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |